Recently, Penn Medicine News wrote a press release describing the new NIAGADS Data Sharing Service (DSS), which will distribute genomic data to qualified investigators. Initially, whole-genome sequence data will be available for 5,000 subjects, with more data to be released within a year.
“Genetic findings for Alzheimer’s disease are critical for identifying targets for therapeutic development,” Li-San Wang, co-director of PNGC, said. “Making these data available is particularly important since there is currently no treatment available that prevents or alters the course of this common and devastating disease.”
You can check out the full press release here: https://www.pennmedicine.org/news/news-releases/2018/july/largest-genetic-database-on-alzheimers-disease-now-reopen-for-business
Please contact firstname.lastname@example.org with questions.